Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors. [electronic resource] by
- Richly, H
- Kupsch, P
- Passage, K
- Grubert, M
- Hilger, R A
- Kredtke, S
- Voliotis, D
- Scheulen, M E
- Seeber, S
- Strumberg, D
Producer: 20040323
In:
International journal of clinical pharmacology and therapeutics vol. 41
Availability: No items available.
|
|
|
11.
|
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial. [electronic resource] by
- Richly, H
- Schultheis, B
- Adamietz, I A
- Kupsch, P
- Grubert, M
- Hilger, R A
- Ludwig, M
- Brendel, E
- Christensen, O
- Strumberg, D
Producer: 20090413
In:
European journal of cancer (Oxford, England : 1990) vol. 45
Availability: No items available.
|
|
|
12.
|
Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer. [electronic resource] by
- Richly, H
- Kupsch, P
- Passage, K
- Grubert, M
- Hilger, R A
- Voigtmann, R
- Schwartz, B
- Brendel, E
- Christensen, O
- Haase, C G
- Strumberg, D
Producer: 20050203
In:
International journal of clinical pharmacology and therapeutics vol. 42
Availability: No items available.
|
|
|
13.
|
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors. [electronic resource] by
- Richly, H
- Henning, B F
- Kupsch, P
- Passarge, K
- Grubert, M
- Hilger, R A
- Christensen, O
- Brendel, E
- Schwartz, B
- Ludwig, M
- Flashar, C
- Voigtmann, R
- Scheulen, M E
- Seeber, S
- Strumberg, D
Producer: 20061107
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|